PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN
2022 · Molecular Cancer · 46 citations
https://doi.org/10.1186/s12943-022-01531-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
367
Citations
8
h-index
8
i10-index
Wenfang Bao is an academic researcher from Shanghai East Hospital. The author has contributed to research in topics: Gout, Hyperuricemia, Uric Acid & Ferroptosis and cancer prognosis & RNA modifications and cancer. The author has an h-index of 8, co-authored 15 publications.
https://doi.org/10.1186/s12943-022-01531-x
https://doi.org/10.1016/j.phrs.2023.106915
https://doi.org/10.6084/m9.figshare.24558157
Click to start Chat